摘要 |
<p>This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide pyrimidine-based compound, preferably a P2Y<SUB>12</SUB> receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae (I) and (Ia-Ic), or tautomers, salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae (I) and (Ia-Ic).</p> |
申请人 |
INSPIRE PHARMACEUTICALS INC.;DOUGLASS, JAMES, G., III;WATSON, PAUL, S.;SHAVER, SAMMY, R.;BEDNARSKI, KRZYSZTOF |
发明人 |
DOUGLASS, JAMES, G., III;WATSON, PAUL, S.;SHAVER, SAMMY, R.;BEDNARSKI, KRZYSZTOF |